NIPER Regularization Scam?
How the Department of Pharmaceuticals Undermined Accountability at NIPER The unfolding saga at NIPER Mohali offers a disturbing glimpse into how powerful bureaucrats and pliable administrators can bury institutional integrity, stonewall due process, and reward questionable conduct — all while funded by public money. At the heart of the controversy is Mr. Jitender Kumar Chandel,…
